The current study was designed to determine the relative distribution
of decreases of N-acetylaspartate (NAA), a marker of axonal damage, be
tween lesions and normal-appearing white matter of patients with estab
lished multiple sclerosis and to test for associations between changes
in the ratio of NAA to creatine/phosphocreatine (NAA : Cr) in those c
ompartments and changes in disability. Data were collected from a 30-m
onth longitudinal study of 28 patients with either a relapsing course
with partial remissons and no progression between attacks (relapsing/r
emitting) (11 patients) or a course of progressively increasing disabi
lity, following a period of relapsing/remitting disease (secondary pro
gressive) (17 patients). Proton magnetic resonance spectroscopic imagi
ng (MRSI) and conventional MRI examinations were performed at 6-8-mont
h intervals with concurrent clinical assessments of disability. Genera
l linear models were used to test associations between MRSI, MRI, lesi
on volume and clinical data. Analysis confirmed that the NAA : Cr rati
o is lower in lesions than in the normal-appearing white matter (-15.3
% in relapsing/remitting multiple sclerosis and -8.8% in secondary pro
gressive multiple sclerosis). The lower NAA : Cr ratio per unit lesion
volume previously observed for secondary progressive relative to rela
psing/remitting patients was found to result from a lower ratio (8.2%,
P < 0.01) in the normal-appearing white matter rather than from any d
ifferences within lesions. The importance of changes in the normal-app
earing white matter was emphasized further with the observation that t
he NAA : Cr ratio in the normal-appearing white matter accounted for m
ost of the observed 15.6% (P < 0.001) decrease in the NAA : Cr ratio i
n the brains of relapsing/remitting patients over the period of study.
The decrease in the NAA : Cr ratio in normal-appearing white matter c
orrelated strongly (P < 0.001) with changes in disability in the relap
sing/remitting subgroup. These results add to data suggesting that axo
nal damage or loss may be responsible for functional impairments in mu
ltiple sclerosis. The accumulation of secondary axonal damage in the n
ormal-appearing white matter may be of particular significance for und
erstanding chronic disability in this disease.